Benzinga | Nov 10, 2021 07:56AM EST

Recursion Pharmaceuticals Q3 EPS $(0.28) Up From $(1.09) YoY, Sales $2.53M Up From $1.02M YoY

Recursion Pharmaceuticals (NASDAQ:RXRX) reported quarterly losses of $(0.28) per share. This is a 74.31 percent increase over losses of $(1.09) per share from the same period last year. The company reported $2.53 million in sales this quarter. This is a 147.22 percent increase over sales of $1.02 million the same period last year.